Concepedia

Publication | Open Access

Ragaglitazar Improves Glycemic Control and Lipid Profile in Type 2 Diabetic Subjects

101

Citations

20

References

2004

Year

Abstract

Ragaglitazar provided glycemic control that was comparable with that of pioglitazone and, compared with placebo, provided significant improvement in the lipid profile.

References

YearCitations

Page 1